Scarica l'app Stockscreener
2.35
0.91%
0.03
Precedente Chiudi:
$2.32
Aprire:
$2.31
Volume 24 ore:
45,460
Relative Volume:
0.16
Capitalizzazione di mercato:
$45.79M
Reddito:
-
Utile/perdita netta:
$-30.26M
Rapporto P/E:
-1.152
EPS:
-2.04
Flusso di cassa netto:
$-24.69M
1 W Prestazione:
-2.05%
1M Prestazione:
-12.97%
6M Prestazione:
+31.52%
1 anno Prestazione:
-72.00%
Intervallo 1D:
$2.30
$2.38
Intervallo di 1 settimana:
$2.30
$2.52
Portata 52W:
$1.11
$10.54
Annovis Bio Inc Stock (ANVS) Company Profile
Nome
Annovis Bio Inc
Settore
Industria
Telefono
484-875-3192
Indirizzo
101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA
Confronta ANVS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANVS
Annovis Bio Inc
|
2.35 | 45.21M | 0 | -30.26M | -24.69M | -2.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
386.83 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.21 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.80 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
729.75 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
338.55 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Annovis Bio Inc Stock (ANVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-10 | Downgrade | D. Boral Capital | Buy → Hold |
| 2024-10-25 | Aggiornamento | Maxim Group | Hold → Buy |
| 2023-12-29 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-07 | Reiterato | Maxim Group | Buy |
Annovis Bio Inc Borsa (ANVS) Ultime notizie
Will Annovis Bio Inc stock hit new highs in YEAR2025 Trading Volume Trends & Weekly Sector Rotation Insights - خودرو بانک
Annovis Bio Raises $21 Million in Public Offering to Advance Alzheimer’s Research - MSN
Annovis Reports Peer-Reviewed Publication Highlighting Pharmacokinetics of Novel Crystal Buntanetap - markets.businessinsider.com
Annovis Bio CEO to Present at Oppenheimer Healthcare Life Sciences Conference - MSN
Aug Macro: Can Annovis Bio Inc disrupt its industryMarket Movers & Weekly High Return Forecasts - خودرو بانک
US Market Wrap: Is Annovis Bio Inc a defensive stockJuly 2025 Decliners & AI Driven Price Forecasts - خودرو بانک
Investment Review: Is Annovis Bio Inc. a cyclical or defensive stockMarket Volume Summary & Free Technical Confirmation Trade Alerts - خودرو بانک
Annovis Bio, Inc. Reports Peer-Reviewed Publication Highlighting Pharmacokinetics of Novel Crystal Buntanetap - MarketScreener
Annovis Bio Publishes Findings on New Crystal Form of Buntanetap in Peer-Reviewed Journal, Supporting Phase 3 Trial in Alzheimer’s Disease - Quiver Quantitative
New Crystal Form of Alzheimer's Drug Buntanetap Extends Patent Protection to 2040s, Matches Original - Stock Titan
Aug Highlights: Is Annovis Bio Inc. impacted by rising rates2025 Stock Rankings & Free Technical Confirmation Trade Alerts - خودرو بانک
Take Profit: What is the target price for Madrigal Pharmaceuticals Inc. stockJuly 2025 PostEarnings & AI Enhanced Trading Alerts - خودرو بانک
Growth Recap: Will Mainz Biomed N.V. be affected by tariffsWeekly Stock Summary & Daily Stock Trend Watchlist - خودرو بانک
Short Squeeze: Is PLURs ROIC above industry average2025 Risk Factors & Weekly High Potential Stock Alerts - خودرو بانک
What makes Annovis Bio Inc stock attractive today2025 Valuation Update & Weekly Watchlist for Consistent Profits - خودرو بانک
Investment Recap: Can Annovis Bio Inc beat the S P 500July 2025 Earnings & Weekly High Potential Alerts - خودرو بانک
Pattern recognition hints at Annovis Bio Inc. upsideWeekly Volume Report & High Conviction Buy Zone Picks - newser.com
Is Annovis Bio Inc. showing signs of accumulationJuly 2025 Movers & Precise Swing Trade Entry Alerts - newser.com
Applying Elliott Wave Theory to Annovis Bio Inc.July 2025 Update & Fast Entry High Yield Tips - newser.com
Annovis Bio’s Promising Alzheimer’s Study: What Investors Need to Know - MSN
Annovis (ANVS) Secures Patent Coverage for Both Forms of Buntanetap - MSN
Annovis Bio CEO to Present at H.C. Wainwright Global Investment Conference - MSN
Annovis Bio Inc. Moves Into Bullish Territory Based on MACDJuly 2025 Review & Verified Entry Point Signals - beatles.ru
Trend Dashboard Flags Annovis Bio Inc. As Potential Swing TradeJuly 2025 Review & Daily Profit Focused Screening - beatles.ru
Can Annovis Bio Inc. disrupt its industry2025 Technical Overview & Stock Portfolio Risk Control - beatles.ru
Chartists See Breakout Potential in Annovis Bio Inc.2025 Volatility Report & Daily Technical Forecast Reports - beatles.ru
Quant Funds Rotate Into Annovis Bio Inc. StockJuly 2025 Highlights & Proven Capital Preservation Tips - beatles.ru
Annovis Bio Advances Phase 3 Alzheimer’s Trial Amid Steady Financial Progress - MSN
How to forecast Annovis Bio Inc. trends using time seriesQuarterly Trade Summary & Daily Volume Surge Trade Alerts - Newser
Is Annovis Bio Inc. impacted by rising ratesTrade Analysis Report & Weekly Watchlist of Top Performers - خودرو بانک
Annovis Bio Inc. recovery potential after sell offPortfolio Performance Report & Long-Term Capital Growth Strategies - Newser
Risk adjusted return profile for Annovis Bio Inc. analyzedJuly 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - Newser
Will Annovis Bio Inc. bounce back from current supportTrade Volume Summary & Free Fast Entry Momentum Trade Alerts - Newser
Forecasting Annovis Bio Inc. price range with options dataJuly 2025 Retail & Growth Focused Stock Reports - Newser
Annovis Bio Advances Alzheimer’s Phase 3 Trial, Strengthens IP Portfolio - MSN
Analyzing drawdowns of Annovis Bio Inc. with statistical tools2025 Year in Review & Expert-Curated Trade Recommendations - Newser
How to escape a deep drawdown in Annovis Bio Inc.2025 Breakouts & Breakdowns & Safe Capital Allocation Plans - Newser
What makes Annovis Bio Inc. stock attractive todayMarket Movement Recap & AI Optimized Trade Strategies - 강소기업뉴스
Technical analysis overview for Annovis Bio Inc. stockIndex Update & Fast Entry High Yield Stock Tips - Newser
What MACD and RSI say about Annovis Bio Inc.2025 Major Catalysts & Verified High Yield Trade Plans - Newser
Has Annovis Bio Inc. formed a bullish divergenceWeekly Profit Report & Weekly Consistent Profit Watchlists - Newser
Regression analysis insights on Annovis Bio Inc. performanceJuly 2025 Breakouts & Free Verified High Yield Trade Plans - Newser
Annovis Bio Inc. stock outlook for YEAR2025 Trade Ideas & AI Based Buy/Sell Signal Reports - Newser
Quarterly Trades: How sensitive is Annovis Bio Inc. to inflationJuly 2025 News Drivers & Consistent Return Strategy Ideas - خودرو بانک
Market Outlook: Does Annovis Bio Inc. stock have upside surprise potential2025 Geopolitical Influence & Advanced Technical Signal Analysis - خودرو بانک
Real time breakdown of Annovis Bio Inc. stock performanceJuly 2025 Chart Watch & Risk Controlled Daily Trade Plans - Newser
Price action breakdown for Annovis Bio Inc.Earnings Trend Report & Weekly Return Optimization Alerts - Newser
Best data tools to analyze Annovis Bio Inc. stock2025 Key Highlights & Smart Swing Trading Alerts - Newser
H.C. Wainwright lowers Annovis Bio stock price target to $10 on extended approval timeline By Investing.com - Investing.com Australia
Alphabet To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
H.C. Wainwright lowers Annovis Bio stock price target to $10 on extended approval timeline - Investing.com
Annovis Bio Inc Azioni (ANVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.16%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):